Patient Reported Outcomes Following Percutaneous Lung Ablation
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 18 Years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study looks at how satisfied patients are with lung tumor ablation, a treatment done through the skin to destroy tumor tissue. It also looks at symptoms before and after the treatment. It is for people having this treatment for lung tumors.
This study evaluates satisfaction with percutaneous ablation and any symptoms experienced before and after the procedure in patients with lung tumors.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- Having lung ablation, a treatment done through the skin to destroy tumor tissue.
Who can't join
- Do not want to take part in research.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: * Undergoing percutaneous lung ablation Exclusion Criteria: * Decline to participate in research
Study sites (1)
MN
- Mayo Clinic in Rochester · Rochester, MN 55905Clinical Trials Referral Office · Study contact · 855-776-0015 · mayocliniccancerstudies@mayo.eduAhmad Parvinian, MD · Principal investigatorMore trials in Rochester